Opioid analgesia for infants in the neonatal intensive care unit

Clinics in Perinatology

Volumn 29, Issue 3, 2002, Pages 493-509

  Taddio, Anna ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BENZODIAZEPINE; FENTANYL; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MUSCLE RELAXANT AGENT; NALOXONE; NORPETHIDINE; OPIATE; PETHIDINE;

ANALGESIA; ARTIFICIAL VENTILATION; BRADYCARDIA; CONSTIPATION; DIAGNOSTIC PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; ILEUS; INFANT; INTUBATION; MUSCLE RIGIDITY; NEWBORN INTENSIVE CARE; PAIN; PATIENT MONITORING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; STRESS; URINE RETENTION;

ANALGESICS, OPIOID; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; PAIN;

EID: 0036742584     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(02)00017-9     Document Type: Review

References (80)

1. Barker DP, Rutter N. Exposure to invasive procedures in neonatal intensive care unit admissions. Arch Dis Child 1995;72:F47-8.
2. Davis PJ, Killian A, Stiller RL, Cook DR, Guthrie RD, Scierka AM. Pharmacokinetics of alfentanil in newborn premature infants and older children. Dev Pharmacol Ther 1989;13:21-7.
3. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part I-pharmacokinetics. Paediatr Anaesth 1997;7:5-11.
4. Saarenmaa E, Neuvonen P, Fellman V. Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants. J Pediatr 2000;136:767-70.
5. Gauntlett IS, Fisher DM, Hertzka RE, Kuhls E, Spellman MJ, Rudolph C. Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 1988;69:683-7.
6. Hartley R, Levene MI. Opioid pharmacology in the newborn. In: Aynsley-Green A, Ward Platt MP, Lloyd-Thomas AR, editors. Stress and pain in infancy and childhood. London, UK: Balliere Tindall; 1995. p. 467-93.
7. Koren G, Maurice L. Pediatric use of opioids. Pediatr Clin N Am. 1989;36(5):1141-56.
8. Gong Q-L, Hedner T, Hedner J, Bjorkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 1991;193:47-56.
9. Pacifici GM, Sawe J, Kager L, Rane A. Morphine glucuronidation in human fetal and adult liver. Eur J Clin Pharmacol 1982;22:553-8.
10. Saneto RP, Fitch JA, Cohen BH. Acute neurotoxicity of meperidine in an infant. Pediatr Neurol 1996;14:339-41.
11. Singleton MA, Rosen JI, Fisher DM. Plasma concentrations of fentanyl in infants, children and adults. Can J Anaesth 1987;35(2):152-5.
12. Jacqz-Aigrain E, Burtin P. Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet 1996;31(6):423-43.
13. Product Information Form. Alfenta. Mississauga, Ontario: Janssen Pharmaceutica Inc.; 1987.
14. Davis PJ, Cook DR. Clinical pahrmacokinetics of the newer intravenous anaesthetic agents. Clin Pharmacokinet 1986;11:18-35.
15. Levene MI, Quinn MW. Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation. Arch Dis Child 1992;67:870-3.
16. Chay PCW, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther 1992;51:334-42.
17. Hartley R, Green M, Quinn M, Levene MI. Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child 1993;69:55-8.
18. Scott CS, Riggs W, Ling EW, Fitzgerald CE, Hill ML, Grunau RVE, et al. Morphine pharmacokinetics and pain assessment in premature newborns. J Pediatr 1999;135:423-9.
19. Grunau RVE, Craig KD. Pain expression in neonates: facial action and cry. Pain 1987;28:395-410.
20. Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 2-clinical use. Paediatr Anaesth 1997;7:93-101.
21. Roth B, Schlunder C, Houben F, Gunther M, Theisohn M. Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Dev Pharmacol Ther 1991;17:121-7.
22. Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr 1991;119:639-43.
23. Marlow N, Weindling AM, Van Peer A, Heykants J. Alfentanil pharmacokinetics in preterm infants. Arch Dis Child 1990;65:349-51.
24. Wiest DB, Ohning BL, Garner SS. The disposition of alfentanil in neonates with respiratory distress. Pharmacotherapy 1991;11:308-11.
25. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983;8:422-46.
26. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988;67:329-37.
27. Van den Nieuwenhuyzen MCO, Engbers FHM, Burm AGL, Lemmens HJM, Vletter AA, van Kleef JW, et al. Computer-controlled infusion of alfentanil for postoperative analgesia. Anesthesiology 1993;79:481-92.
28. Anand KJS. Relationships between stress responses and clinical outcome in newborns, infants, and children. Crit Care Med 1993;21:S358-9.
29. Anand KJ, Hickey PR. Halothane-morphine compared with high dose sufentanil for anesthesia and post-operative analgesia in neonatal cardiac surgery. N Engl J Med 1992;326:1-9.
30. Anand KJS, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987;1:243-8.
31. Hughes D, Murphy JF, Dyas J, Robinson JA, Riad-Fahmy D, Hughes I. Blood spot glucorticoid concentrations in ill preterm infants. Arch Dis Child 1987;62:1014-8.
32. Barker DP, Rutter N. Stress, severity of illness, and outcome in ventilated preterm infants. Arch Dis Child 1996;75:F187-90.
33. Anand KJS, McIntosh N, Lagercrantz H, Pelausa E, Young TE, Vasa R. Analgesia and sedation in preterm neonates who require ventilatory support. Arch Pediatr Adolesc Med 1999;153:331-8.
34. Quinn MW, Wild J, Dean HG, Hartley R, Rushforth JA, Puntis JWL, et al. Randomised doubleblind controlled trial of effect of morphine on catecholamine concentrations in ventilated preterm babies. Lancet 1993;342:324-7.
35. Orsini AJ, Leef KH, Costarino A, Dettorre MD, Stefano JL. Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr 1996;129:140-5.
36. Dyke MP, Kohan R, Evans S. Morphine increases synchronous ventilation in preterm infants. J Paediatr Chid Health 1995;31:176-9.
37. Richardson DK, Kahn DJ, SNAP-II Study Group. Inter-NICU variation in narcotics use [abstract 9]. Pediatrics 1996;98(3):577.
38. Anand KJS. International evidence-based group for neonatal pain. Arch Pediatr Adolesc Med 2001;155:173-80.
39. Lawrence J, Alcock D, McGrath P, Kay J, MacMurray SB, Dulberg C. The development of a tool to assess neonatal pain. Neonatal Netw 1993;12:59-66.
40. Saarenmaa E, Huttunen P, Leppaluoto J, Meretoja O, Fellman V. Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: a randomized trial. J Pediatr 1999;134:144-50.
41. Kennedy K, Tyson JE. Narcotic analgesia for ventilated newborns: are placebo-controlled trials ethical and necessary? J Pediatr 1999;134(2):127-9.
42. Yaster M, Nichols DG, Deshpande JK, Wetzel RC. Midazolam-fentanyl intravenous sedation in children: case report of respiratory arrest. Pediatrics 1990;86(3):463-7.
43. Taguchi A, Sharma N, Saleem RM, Sessler DI, Carpenter RL, Seyedsadr M, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. New Engl J Med 2001;345(13):935-40.
44. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther 1965;6(4):454-61.
45. Lynn AM, Nespeca M, Opheim KE, et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg 1993;77:695-701.
46. Acute Pain Management Guideline Panel. Acute pain management in infants, children, and adolescents: operative and medical procedures. Quick reference guide for clinicians, No. 92-0020. MD: AHCPR Pub; 1992.
47. Vaughn PR, Townsend SF, Thilo EH, McKenzie S, Moreland S, Kawato K. Comparison of continuous infusion of fentanyl to bolus dosing in neonates after surgery. J Pediatr Surg 1996;31(12):1616-23.
48. Purcell-Jones G, Dormon F, Sumner E. The use of opioids in neonates. A retrospective study of 933 cases. Anaesthesia 1987;42:1316-20.
49. Tholl DA, Wager MS, Sajous CH, Myers TF. Morphine use and adverse effects in a neonatal intensive care unit. Am J Hosp Pharm 1994;51:2801-3.
50. Pokela M-L, Olkkola KT, Seppala T, Koivisto M. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993;20:26-34.
51. Suresh S, Anand KJS. Opioid tolerance in neonates: mechanisms, diagnosis, assessment, and management. Sem Perinatol 1998;22(5):425-33.
52. Bovill JG, Sebel PS, Stanley TH. Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology 1984;61:731-55.
53. Rutter N, Evans N. Cardiovascular effects of an intravenous bolus of morphine in the ventilated preterm infant. Arch Dis Child (Fetal Neonatal Ed) 2000;83:F101-03.
54. Sabatino G, Quartulli L, DiFabio S, Ramenghi LA. Hemodynamic effects of intravenous morphine infusion in ventilated preterm babies. Early Hum Dev 1997;47:263-70.
55. Rabe H, Jorch G. Cerebral hemodynamics in perinatal pharmacology. Dev Pharmacol Ther 1991;17:128-32.
56. Scamman FL. Fentanyl-O2-N20 rigidity and pulmonary compliance. Anesth Analg 1983;62:332-4.
57. Lajarrige C, Adafer M, Mouthemy G, et al. Effet du fentanyl sur la ventilation du premature. Arch Fr Pediatr 1993;50:271-4.
58. Van Lemmen RJ, Semmekrot BA. Muscle rigidity causing life-threatening hypercapnia following fentanyl administration in a premature infant. Eur J Pediatr 1996;155(12):1067.
59. Pokela M-L, Ryhanen PT, Koivisto ME, et al. Alfentanil-induced rigidity in newborn infants. Anesth Analg 1992;75:252-7.
60. Hickey PR, Hansen DD, Wessel DL, Lang P, Jonas RA, Elixson EM. Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesth Analg 1985;64:1137-42.
61. Wells S, Williamson M, Hooker D. Fentanyl-induced chest wall rigidity in a neonate: a case report. Heart Lung 1994;23:196-8.
62. Koren G, Butt W, Chinyanga H, et al. Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. J Pediatr 1985;107:963-7.
63. Da Silva O, Alexandrou D, Knoppert D, Young GB. Seizure and electroencephalographic changes in the newborn period induced by opiates and corrected by naloxone infusion. J Perinatol 1999;19(2):120-3.
64. Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenson MB. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990;73:1136-40.
65. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 1994;22:763-7.
66. Grehn LS. Adverse responses to analgesia, sedation, and neuromuscular blocking agents in infants and children. AACN Clin Issues 1998;9(1):36-48.
67. Norton SJ. Aftereffects of morphine and fentanyl analgesia: a retrospective study. Neonatal Netw 1988;7(3):25-8.
68. Yaster M, Berde C, Billet C. The management of opioid and benzodiazepine dependence in infants, children, and adolescents. Pediatrics 1996;98(1):135-40.
69. Rahman W, Fitzgerald M, Aynsley-Green A, Dickenson A. The effects of neonatal exposure to inflammation and/or morphine on neuronal responses and morphine analgesia in adult rats. In: Jensen TS, Turner JA, Wiesenfeld-Hallin, editors. Proceedings of the Eighth World Congress on Pain, Progress in pain research and management, vol 8. Seattle(WA): IASP Press; 1997. p. 783-94.
70. MacGregor R, Evans D, Sugden D, Gaussen T, Levene M. Outcome at 5-6 years of prematurely born children who received morphine as neonates. Arch Dis Child (Fetal Neonatal Ed) 1998;79:F40-3.
71. Hopkinson RB, Freeman JW. Therapeutic progress-XXX. Therapeutic progress in intensive care sedation and analgesia: part I-principles. J Clin Pharm Ther 1988;13:33-40.
72. Gill AM, Cousins A, Nunn AJ, Choonara IA. Opiate-induced respiratory depression in pediatric patients. Ann Pharmacother 1996;30:125-9.
73. McRorie TI, Lynn AM, Nespeca MK, Opheim KE, Slattery JT. The maturation of morphine clearance and metabolism. Am J Dis Child 1992;146:972-6.
74. Bhat R, Chari G, Gulati A, Aldana O, Velamati R, Bhargava H. Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. J Pediatr 1990;117:477-81.
75. Burns AM, Shelly MP, Park GR. The use of sedative agents in critically ill patients. Drugs 1992;43(4):507-15.
76. Mather LE. Pharmacokinetic and pharmacodynamic factors influencing the choice, dose and route of administration of opiates for acute pain. Clin Anesthesiol 1983;1(1):17-40.
77. Pokela M-L, Olkkola KT, Koivisto M, Ryhanen P. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 1992;52:342-9.
78. Nation RL. Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther 1981;29:472-9.
79. Bussche GV, Noorduin H. Alfentanil and sufentanil: towards a more specific use of narcotics in anesthesia. Drug Dev Res 1986;8:341-6.
80. American Academy of Pediatrics. Canadian Paediatric Society. Prevention and management of pain and stress in the neonate. Pediatrics 2000;105(2):454-61.